Annual Accounts Payable
$1.88 M
-$681.00 K-26.60%
31 December 2023
Summary:
Galmed Pharmaceuticals annual accounts payable is currently $1.88 million, with the most recent change of -$681.00 thousand (-26.60%) on 31 December 2023. During the last 3 years, it has fallen by -$5.17 million (-73.33%). GLMD annual accounts payable is now -73.33% below its all-time high of $7.05 million, reached on 31 December 2020.GLMD Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$1.34 M
+$139.00 K+11.55%
30 September 2024
Summary:
Galmed Pharmaceuticals quarterly accounts payable is currently $1.34 million, with the most recent change of +$139.00 thousand (+11.55%) on 30 September 2024. Over the past year, it has dropped by -$132.00 thousand (-8.96%). GLMD quarterly accounts payable is now -80.95% below its all-time high of $7.05 million, reached on 31 December 2020.GLMD Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GLMD Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -26.6% | -9.0% |
| 3 y3 years | -73.3% | -74.4% |
| 5 y5 years | +3.6% | -51.1% |
GLMD Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -73.3% | at low | -74.4% | +11.6% |
| 5 y | 5 years | -73.3% | +3.6% | -81.0% | +11.6% |
| alltime | all time | -73.3% | +368.6% | -81.0% | +345.9% |
Galmed Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.34 M(+11.6%) |
| June 2024 | - | $1.20 M(-13.0%) |
| Mar 2024 | - | $1.38 M(-26.4%) |
| Dec 2023 | $1.88 M(-26.6%) | $1.88 M(+27.5%) |
| Sept 2023 | - | $1.47 M(-31.1%) |
| June 2023 | - | $2.14 M(-5.6%) |
| Mar 2023 | - | $2.27 M(-11.5%) |
| Dec 2022 | $2.56 M(-47.4%) | $2.56 M(-46.1%) |
| Sept 2022 | - | $4.75 M(+127.3%) |
| June 2022 | - | $2.09 M(-56.8%) |
| Mar 2022 | - | $4.83 M(-0.7%) |
| Dec 2021 | $4.87 M(-30.9%) | $4.87 M(-6.9%) |
| Sept 2021 | - | $5.23 M(-7.0%) |
| June 2021 | - | $5.63 M(-3.0%) |
| Mar 2021 | - | $5.80 M(-17.6%) |
| Dec 2020 | $7.05 M(+17.5%) | $7.05 M(+36.8%) |
| Sept 2020 | - | $5.15 M(+32.9%) |
| June 2020 | - | $3.88 M(-27.3%) |
| Mar 2020 | - | $5.33 M(-11.2%) |
| Dec 2019 | $6.00 M | $6.00 M(+118.8%) |
| Sept 2019 | - | $2.74 M(+6.4%) |
| June 2019 | - | $2.58 M(+43.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $1.80 M(-0.9%) |
| Dec 2018 | $1.81 M(-20.3%) | $1.81 M(+40.8%) |
| Sept 2018 | - | $1.29 M(-45.1%) |
| June 2018 | - | $2.35 M(+6.8%) |
| Mar 2018 | - | $2.20 M(-3.5%) |
| Dec 2017 | $2.28 M(-27.1%) | $2.28 M(+15.8%) |
| Sept 2017 | - | $1.97 M(-16.9%) |
| June 2017 | - | $2.37 M(-6.8%) |
| Mar 2017 | - | $2.54 M(-18.7%) |
| Dec 2016 | $3.12 M(+38.2%) | $3.12 M(+83.3%) |
| Sept 2016 | - | $1.70 M(-42.6%) |
| June 2016 | - | $2.96 M(+0.5%) |
| Mar 2016 | - | $2.95 M(+30.6%) |
| Dec 2015 | $2.26 M(+158.2%) | $2.26 M(+100.6%) |
| Sept 2015 | - | $1.13 M(-8.4%) |
| June 2015 | - | $1.23 M(+7.1%) |
| Mar 2015 | - | $1.15 M(+31.1%) |
| Dec 2014 | $875.00 K(-35.4%) | $875.00 K(-56.2%) |
| Sept 2014 | - | $2.00 M(+563.5%) |
| June 2014 | - | $301.00 K(-72.6%) |
| Mar 2014 | - | $1.10 M(-18.8%) |
| Dec 2013 | $1.35 M(+237.9%) | $1.35 M |
| Dec 2012 | $401.00 K | - |
FAQ
- What is Galmed Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Galmed Pharmaceuticals?
- What is Galmed Pharmaceuticals annual accounts payable year-on-year change?
- What is Galmed Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Galmed Pharmaceuticals?
- What is Galmed Pharmaceuticals quarterly accounts payable year-on-year change?
What is Galmed Pharmaceuticals annual accounts payable?
The current annual accounts payable of GLMD is $1.88 M
What is the all time high annual accounts payable for Galmed Pharmaceuticals?
Galmed Pharmaceuticals all-time high annual accounts payable is $7.05 M
What is Galmed Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, GLMD annual accounts payable has changed by -$681.00 K (-26.60%)
What is Galmed Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of GLMD is $1.34 M
What is the all time high quarterly accounts payable for Galmed Pharmaceuticals?
Galmed Pharmaceuticals all-time high quarterly accounts payable is $7.05 M
What is Galmed Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, GLMD quarterly accounts payable has changed by -$132.00 K (-8.96%)